Elevance Health, Inc. (ELV)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 49,776 | 48,891 | 45,106 | 43,886 |
| Operating expense | 4,997 | 5,300 | 5,269 | 5,066 |
| Benefit expense | 36,706 | 35,312 | 32,949 | 30,572 |
| Interest expense | 341 | 344 | 300 | 280 |
| Cost of products sold | 5,293 | 4,983 | 5,093 | 4,820 |
| Amortization of other intangible assets | 147 | 155 | 122 | 162 |
| Total expenses | 47,484 | 46,094 | 43,733 | 40,900 |
| Income before income tax expense | 2,292 | 2,797 | 1,373 | 2,986 |
| Income tax expense | 548 | 613 | 365 | 685 |
| Net income | 1,744 | 2,184 | 1,008 | 2,301 |
| Net income attributable to noncontrolling interests | 1 | 1 | -8 | 1 |
| Shareholders net income | 1,743 | 2,183 | 1,016 | 2,300 |
| Basic (in dollars per share) | 7.74 | 9.64 | 4.38 | 9.91 |
| Diluted (in dollars per share) | 7.72 | 9.61 | 4.36 | 9.85 |
| Denominator for basic shareholders' earnings per share weighted-average shares (in shares) | 225,200,000 | 226,400,000 | 231,900,000 | 232,200,000 |
| Denominator for diluted shareholders' earnings per share (in shares) | 225,800,000 | 227,200,000 | 233,100,000 | 233,400,000 |